SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181157-09-000002
Filing Date
2009-05-22
Accepted
2009-05-22 11:51:33
Documents
1
Period of Report
2009-05-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 12308
  Complete submission text file 0001181157-09-000002.txt   13964
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Issuer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address
Business Address
KLEMA CATHY (Reporting) CIK: 0001181157 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27570 | Film No.: 09847729